MiMedx Group Inc. (NASDAQ:MDXG) has a beta value of 1.77 and has seen 1.01 million shares traded in the last trading session. The company, currently valued at $368.03M, closed the last trade at $3.07 per share which meant it lost -$0.17 on the day or -5.25% during that session. The MDXG stock price is -183.06% off its 52-week high price of $8.69 and 0.98% above the 52-week low of $3.04. If we look at the company’s 10-day average daily trading volume, we find that it stood at 0.84 million shares traded. The 3-month trading volume is 513.08K shares.
The consensus among analysts is that MiMedx Group Inc. (MDXG) is a Buy stock at the moment, with a recommendation rating of 2.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 2 have rated it as a Hold, with 2 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is -$0.06.
MiMedx Group Inc. (NASDAQ:MDXG) trade information
Sporting -5.25% in the red in last session, the stock has traded in the red over the last five days, with the highest price hit on Tuesday, 09/20/22 when the MDXG stock price touched $3.07 or saw a rise of 13.03%. Year-to-date, MiMedx Group Inc. shares have moved -49.17%, while the 5-day performance has seen it change -11.27%. Over the past 30 days, the shares of MiMedx Group Inc. (NASDAQ:MDXG) have changed -21.68%. Short interest in the company has seen 3.67 million shares shorted with days to cover at 6.33.
Wall Street analysts have a consensus price target for the stock at $11.67, which means that the shares’ value could jump 73.69% from current levels. The projected low price target is $8.00 while the price target rests at a high of $16.00. In that case, then, we find that the current price level is -421.17% off the targeted high while a plunge would see the stock gain -160.59% from current levels.
MiMedx Group Inc. (MDXG) estimates and forecasts
Figures show that MiMedx Group Inc. shares have underperformed across the wider relevant industry. The company’s shares have lost -35.23% over the past 6 months, with this year growth rate of -113.33%, compared to 1.40% for the industry. Other than that, the company has, however, lowered its growth outlook for the 2022 fiscal year revenue. Growth estimates for the current quarter are -100.00% and 25.00% for the next quarter. Revenue growth from the last financial year stood is estimated to be 5.60%.
3 analysts offering their estimates for the company have set an average revenue estimate of $65.06 million for the current quarter. 3 have an estimated revenue figure of $71.72 million for the next quarter concluding in Sep 2022.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 31.85% over the past 5 years. Earnings growth for 2022 is a modest 80.70% while over the next 5 years, the company’s earnings are expected to increase by 15.00%.
MiMedx Group Inc. is expected to release its next earnings report between March 07 and March 11 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
MiMedx Group Inc. (NASDAQ:MDXG)’s Major holders
Insiders own 1.98% of the company shares, while shares held by institutions stand at 60.89% with a share float percentage of 62.12%. Investors are also buoyed by the number of investors in a company, with MiMedx Group Inc. having a total of 205 institutions that hold shares in the company. The top two institutional holders are Essex Woodlands Management Inc. with over 23.42 million shares worth more than $110.29 million. As of Mar 30, 2022, Essex Woodlands Management Inc. held 21.23% of shares outstanding.
The other major institutional holder is Blackrock Inc., with the holding of over 7.28 million shares as of Mar 30, 2022. The firm’s total holdings are worth over $34.3 million and represent 6.60% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are iShares Russell 2000 ETF and Vanguard Total Stock Market Index Fund. As of Jun 29, 2022, the former fund manager holds about 2.41% shares in the company for having 2.66 million shares of worth $9.24 million while later fund manager owns 2.25 million shares of worth $10.58 million as of Mar 30, 2022, which makes it owner of about 2.04% of company’s outstanding stock.